We explicitly addressed this point here to avoid over-interpretation of the results presented and to encourage other groups investigating DCLK1-IN-1 in RCC or other cancer types to build on this work in finding a meaningful concentration range for this important new DCLK1 targeting modality. Here, DCLK1 is linked to renal cell carcinoma.